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22 Abstract
23 Alphaviruses are typically arthropod-borne, and many are important pathogens such as 
24 chikungunya virus. Alphaviruses encode four nonstructural proteins (nsP1 to 4), initially 
25 produced as a polyprotein P1234. nsP4 is the core RNA-dependent RNA polymerase but all 
26 four nsPs are required for RNA synthesis. The early replication complex (RC) formed by the 
27 polyprotein P123 and nsP4 synthesizes minus RNA strands, and the late RC composed of fully 
28 processed nsP1 to nsP4 is responsible for the production of genomic and subgenomic plus 
29 strands. Different parts of nsP4 recognize the promoters for minus and plus strands but the 
30 binding also requires the other nsPs. The alphavirus polymerase has been purified and is 
31 capable of de novo RNA synthesis only in the presence of the other nsPs. The purified nsP4 
32 also has terminal adenylyltransferase activity, which may generate the poly(A) tail at the 3′ 
33 end of the genome. Membrane association of the nsPs is vital for replication, and alphaviruses 
34 induce membrane invaginations called spherules, which form a microenvironment for RNA 
35 synthesis by concentrating replication components and protecting double-stranded RNA 
36 intermediates. The RCs isolated as crude membrane preparations are active in RNA synthesis 
237 in vitro, but high-resolution structure of the RC has not been achieved, and thus the 
38 arrangement of viral and possible host components remains unknown. For some 
39 alphaviruses, Ras-GTPase-activating protein (Src-homology 3 (SH3) domain)-binding proteins 
40 (G3BPs) and amphiphysins have been shown to be essential for RNA replication and are 
41 present in the RCs. Host factors offer an additional target for antivirals, as only few alphavirus 
42 polymerase inhibitors have been described.
43
44
45 1. Alphavirus genome structure and replicase proteins
46
47 Alphaviruses belong to the family Togaviridae together with the genus Rubivirus, which 
48 contains only one member, rubella virus (Table 1). Most alphaviruses are arthropod-borne 
49 viruses, and several are important human and/or animal pathogens, causing either fever, rash 
50 and arthritis (Old World alphaviruses, including chikungunya virus (CHIKV), Ross River virus 
51 (RRV) and Sindbis virus (SINV)), or encephalitis (New World alphaviruses, e.g. Venezuelan 
52 equine encephalitis virus (VEEV)). The alphavirus genome is a single positive-strand RNA of 
53 ~11-12 kb with a 5′ cap0 structure and 3′ poly(A). The two open reading frames encode the 
54 nonstructural (ns) or replicase polyprotein, and the structural polyprotein expressed via a 
55 subgenomic RNA (Fig. 1) (Strauss and Strauss, 1994). The ns polyprotein is processed in a 
56 highly regulated sequence to four final products, the nonstructural proteins (nsPs) 1-4 
57 (Kääriäinen and Ahola, 2002). nsP1 is the viral capping enzyme and membrane anchor of the 
58 replication complex (RC) (Ahola and Kääriäinen, 1995; Spuul et al., 2007), while nsP2 is an 
59 RNA helicase and the protease responsible for the ns polyprotein processing (Das et al., 2014; 
60 Hardy and Strauss, 1989; Vasiljeva et al., 2003). nsP3 interacts with several host proteins and 
61 may modulate protein poly- and mono-ADP-ribosylation (Kim et al., 2016; Li et al., 2016), and 
62 nsP4 is the core viral RNA-dependent RNA polymerase (RdRp) (Rubach et al., 2009). Structural 
63 information is only available for the protease region of nsP2 and the folded N-terminal 
64 portions of nsP3 (Shin et al., 2012).
65 The nsP4 polymerase is the most highly conserved protein in alphaviruses. Even nsP4s 
66 of the most diverged alphaviruses, the salmonid alphaviruses, are ≥50 % identical in amino 
67 acid sequence with the other alphaviral nsP4s (Forrester et al., 2012; Weston et al., 2002). 
368 Within the mammalian/avian alphaviruses, the identities are even higher, e.g CHIKV nsP4 
69 identity varying from 71% (with Barmah Forest virus, BFV) to 91% (with O'nyong-nyong virus, 
70 ONNV) (Khan et al., 2002). Alphavirus nsP4 is ~610 amino acids in length, containing a large 
71 C-terminal domain related to other viral RdRps, and an alphavirus-specific ~150 amino acid 
72 N-terminal domain. The N-terminal domain is crucial for virus replication. It may be partially 
73 disordered structurally and it appears to interact with the other nsPs in the RCs (Rupp et al., 
74 2011). Beyond the family Togaviridae, the alphaviruses belong to the large alphavirus-like 
75 superfamily that contains the animal hepeviruses and numerous genera of plant viruses 
76 (Koonin et al., 2015). All of these possess within their replicase proteins domains related to 
77 the capping enzyme nsP1, the helicase domain of nsP2 and the polymerase nsP4. When the 
78 predicted secondary structures of the RdRps from bromo- and tobamoviruses were compared 
79 to the partial crystal structure of poliovirus polymerase, these alphavirus superfamily 
80 members showed the typical RdRp structure with fingers, palm containing the GDD motif, and 
81 thumb domains (O'Reilly and Kao, 1998). In addition, comparison revealed a region preceding 
82 the fingers domain, which is unique to the RdRps and might be essential for the 
83 oligomerization of the polymerase. There are no structures available for the alphavirus nsP4, 
84 nor for any of the polymerases within the alphavirus-like superfamily. Now that structures 
85 have been solved for some of the negative-strand RNA virus polymerases (Pflug et al., 2017), 
86 the alphavirus superfamily may be the most significant branch of RdRps entirely lacking 
87 structural information. The biochemical characterization of nsP4 has also been challenging, 
88 as discussed in the next section. Therefore, much of this review will focus on the activities and 
89 properties of the alphavirus RC as a whole. 
90
91
92 2. Biochemical characteristics of nsP4: RNA synthesis and polyadenylation
93 Most of the work on the replication and RNA synthesis of alphaviruses has been done with 
94 SINV and Semliki Forest virus (SFV) (Rupp et al., 2015). Together with the distant sequence 
95 relationship to other RdRps, analysis of temperature-sensitive (ts) mutants defective in RNA 
96 synthesis indicated that nsP4 is the catalytically active core polymerase subunit (Barton et al., 
97 1988; Hahn et al., 1989a; Sawicki et al., 1990). 
498 SINV mutants ts6 and ts110 each have a single base substitution in nsP4 causing glycine 
99 to glutamic acid change at position 153 or 324, respectively. These substitutions are located 
100 within highly conserved regions of nsP4 (Hahn et al., 1989a). In vitro RNA synthesis of ts6 
101 shows that the RCs are stable at nonpermissive temperature but fail to elongate RNA strands 
102 indicating that the elongation capacity of the polymerase is inactivated (Barton et al., 1988). 
103 The in vitro RNA synthesis of the RCs is reactivated when they are returned to the permissive 
104 temperature.
105 SINV nsP4 has been expressed in E. coli and purified resulting in the full-length 
106 polymerase with an authentic N-terminal tyrosine and de novo RNA-synthesis activity but only 
107 when supplied with the polyprotein P123 (Rubach et al., 2009). Remarkably, the purified nsP4 
108 is capable of forming the RCs with P123 resulting in the synthesis of discrete template-length 
109 minus strands from the provided plus-strand templates. Furthermore, nsP4 produced in 
110 bacteria has the same template requirements as the mammalian nsP4. The core catalytic 
111 domain (Δ97nsP4, in which the N-terminal 97 amino acids are deleted) has also been 
112 expressed in E. coli and purified as a monomer (Tomar et al., 2006). Interestingly, Δ97nsP4 
113 lacks de novo copying activity, even when combined with the polyprotein P123 (Rubach et al., 
114 2009; Tomar et al., 2006). Thus, the 97 N-terminal residues seem to be crucial for the RdRp 
115 activity. The polyprotein P123 might be required in the template recognition or it may activate 
116 nsP4 through protein-protein interactions.
117 It is intriguing that nsP4 has also been shown to synthesize RNA in vitro in the absence 
118 of the other viral nsPs (Thal et al., 2007). SINV nsP4 was purified using detergent solubilisation 
119 of the membrane fraction from cells expressing uncleavable P123 and nsP4. The soluble form 
120 of nsP4 was able to synthesize template-length RNA from both minus- and plus-strand 
121 transcripts in the absence of the other nsPs. The authors suggest that the other components 
122 in the RC, determine the polarity of the RNA synthesized by nsP4. However, the ability of the 
123 detergent-solubilized nsP4 to synthesize RNA without the other nsPs is in conflict with the 
124 result that nsP4 purified from a bacterial expression system requires the polyprotein P123 for 
125 de novo RNA synthesis (Rubach et al., 2009). It is speculated that host proteins remaining in 
126 the same fraction as the soluble nsP4 may affect the RNA synthesis, but the bacterially 
127 produced nsP4 was unable to synthesize RNA even when combined with animal cell extracts 
128 (Rubach et al., 2009; Thal et al., 2007).  
5129 Both the full-length and N-terminally truncated nsP4 possess terminal, divalent cation-
130 dependent adenylyltransferase (TATase) activity, independent of P123, nsP1, nsP2, or nsP3 
131 (Rubach et al., 2009; Tomar et al., 2006). At least 11-12 adenylate residues in the poly(A) tail 
132 next to the 3’ conserved sequence element (CSE) are required for SINV RNA replication and 
133 efficient production of full-length minus strands (Hardy and Rice, 2005), and the TATase 
134 activity of nsP4 may play an important role in generating genome poly(A). However, it is not 
135 known if the poly(A) tail is added in a template-dependent or independent manner and if 
136 cellular and/or viral factors are responsible for the polyadenylation. Previously, it was 
137 suggested that the 5’ end of the minus strand is a poly(U) tract and the initiation of the plus-
138 strand synthesis occurs within this poly(U) tail resulting in the poly(A) tail (Frey and Strauss, 
139 1978; Sawicki and Gomatos, 1976). However, more recent evidence shows that the initiation 
140 of the minus-strand synthesis occurs immediately after the poly(A) tail (Hardy, 2006) 
141 indicating that a template-independent mechanism is used to add the poly(A) tail. 
142 Furthermore, it has been observed that SINV poly(A) tail is regenerated in vivo when RNA 
143 without the poly(A) tail is transfected into cells (Hill et al., 1997; Raju et al., 1999). A signal for 
144 this polyadenylation is located within the 29 3’-terminal nucleotides of the SINV genome (Raju 
145 et al., 1999).
146 Altogether, data imply that the TATase activity of nsP4 has a potential role in 
147 maintenance and repair of the poly(A) tail, and the work by Tomar et al. (2006) and Rubach 
148 et al. (2009) indicate that the poly(A) tail is added by a non-templated mechanism. The N-
149 terminally truncated nsP4 (Δ97nsP4) adds adenine to the 3’ end of an acceptor RNA in the 
150 presence of different divalent cations, and mutations have confirmed the role of the 
151 alphavirus GDD motif in metal binding (Tomar et al., 2006). Other viral or host factors, or the 
152 97 N-terminal residues, might be needed for the template recognition as Δ97nsP4 shows no 
153 sequence specificity in the TATase activity. Participation of other factors in nsP4 TATase 
154 activity is further supported by the observation that Δ97nsP4 adds only two to four adenylate 
155 residues while the alphavirus poly(A) tail is ~70 nt. Furthermore, the full-length nsP4 shows 
156 more robust TATase activity than Δ97nsP4 demonstrating the importance of the 97 N-
157 terminal residues (Rubach et al., 2009). However, it remains to be studied whether nsP4 
158 TATase activity is responsible for the in vivo polyadenylation of alphavirus RNA.
159 Mutations in nsP4 enable SINV to replicate in cells with lowered levels of rNTPs (Li et 
160 al., 2004; Lin et al., 2002; Lin et al., 2000). Pyrazofurin (PFZ), which is a cytidine analog 
6161 decreasing UTP and CTP levels, inhibits SINV replication (Lin et al., 2000). Three amino acid 
162 substitutions in nsP4 (Met287 to Leu, Lys592 to Ile, and Pro609 to Thr) are required for the 
163 PFZ-resistant phenotype of SINV. One of the substitutions (M287L) is located in the predicted 
164 fingers domain and the two others in the thumb domain of the polymerase, and it is suggested 
165 that these three substitutions, especially in the fingers, alter the rNTP-binding pocket 
166 increasing affinity for UTP and CTP. There is also a SINV mutant resistant to 
167 cyclopentenylcytosine (CPC), which reduces the level of CTP. One substitution in nsP4 (Leu585 
168 to Phe) confers the resistance against CPC. This mutant has a lower Km for CTP compared to 
169 the wild type. The CPC-resistant mutant is sensitive to PFZ while the PFZ-resistant mutant is 
170 also resistant to CPC. As these two mutants have amino acid substitutions at different 
171 positions, it is suggested that the polymerase uses different amino acids to bind different 
172 nucleotides (Li et al., 2004).
173 High-fidelity variants of nsP4 as well as nsP2 are more resistant to inhibitors of 
174 nucleoside biosynthesis indicating that viruses could use fidelity changes to adapt to 
175 intracellular nucleotide depletions (Stapleford et al., 2015). Passaging of CHIKV in the 
176 presence of ribavirin, which is an RNA nucleoside analog, resulted in a mutant with a cysteine-
177 to-tyrosine substitution at position 483 of nsP4 (Coffey et al., 2011). This substitution of the 
178 conserved cysteine increased replication fidelity of the polymerase and thus decreased 
179 genetic diversity and fitness of the virus. The mutant is moderately attenuated in mammalian 
180 and mosquito hosts. A ribavirin- and 5-fluorouracil-resistant variant of CHIKV nsP2 has also 
181 been shown to increase the fidelity of the polymerase. This nsP2 variant exhibits delayed 
182 helicase activity, yet replication kinetics is increased (Stapleford et al., 2015). Thus, nsP2 and 
183 nsP4 may interact in the RCs to regulate the fidelity of the polymerase, and the interaction 
184 between these proteins has been observed in yeast-two hybrid and ELISA experiments 
185 (Sreejith et al., 2012; Stapleford et al., 2015). 
186 Further substitutions at the Cys483 of CHIKV nsP4 have been generated to decrease the 
187 replication fidelity (Rozen-Gagnon et al., 2014). Polymerase variants with higher mutation 
188 frequencies were attenuated in vivo but showed no major replication defects in mammalian 
189 cells. On the other hand, these mutants had major defects in RNA synthesis in mosquito cells. 
190 The same effects were also observed with analogous mutations in SINV. Thus, manipulation 
191 of the polymerase fidelity offers a tool to attenuate alphaviruses in both mammalian and 
7192 insect cells for example in order to develop vaccines (Coffey et al., 2011; Rozen-Gagnon et al., 
193 2014).
194 The study of SINV RdRp mutators by Poirier et al. (2016) suggests a tight link between 
195 fidelity, recombination and defective interfering particle (DI) production. The mutators 
196 contain point mutations in viral polymerase and it was shown that the mutators have the 
197 ability to recombine in higher rate than wild-type viruses, leading to overproduction of DIs 
198 (Poirier et al., 2016). Recombination in alphaviruses was originally shown by the formation of 
199 DIs, virions with truncated viral genomes that accumulate during replication. They utilize full-
200 length viruses for multiplication and thus interfere with their replication (Poirier et al., 2016). 
201 The alphavirus DIs may contain duplicated, deleted or rearranged sequences and even cellular 
202 RNAs (Monroe and Schlesinger, 1983, 1984), but retain cis-acting sequence elements that are 
203 necessary for replication and packaging. Analyses of SFV and SINV DI genomes have provided 
204 important information on these critical elements needed for virus multiplication (reviewed in 
205 (Strauss and Strauss, 1994, 1997)). 
206 Recombination seems to be somewhat less common in alphaviruses as compared to other 
207 groups of positive-strand RNA viruses, and both homologous as well as nonhomologous 
208 recombination has been described (Raju et al., 1995; Strauss and Strauss, 1997). In laboratory 
209 experiments, SINV constructs that were defective when introduced to the cells alone, were 
210 able to complement each other, giving rise to infectious recombinants (Weiss and Schlesinger, 
211 1991). The recombination studies have given information especially on the 3´ end of the 
212 genome and its minimal requirements for minus strands synthesis (Hill et al., 1997) and on 
213 recombination hot spots (Hajjou et al., 1996). 
214 Viruses must be able to repair their genomes and a mechanism for the 3'-end repair 
215 pathway of alphaviruses has been suggested. Alphaviruses are able to add in vivo AU-rich 
216 sequences next to the poly(A) tail in genomes lacking the 3’ CSE and infectious progeny viruses 
217 are made (Hill et al., 1997; Raju et al., 1999). The poly(A) tail is the prerequisite for these AU 
218 additions. It has been proposed that the polymerase stammers on AU-rich sequences and 
219 sliding, jumping, and stammering of the polymerase result in addition of such motifs to newly 
220 synthesized minus strands. 
221 Alphavirus polymerases are considered to be viral template specific. SFV nsP4 is, 
222 however, at least to some extent, able to use other than viral RNA as a template to make 
223 double-stranded RNA (dsRNA) as it makes 5’-ppp dsRNA using host cell RNA as a template.  
8224 (Nikonov et al., 2013). This, on the other hand, induces interferon-beta production mediated 
225 by retinoic acid-inducible gene I (RIG-I)-like receptors, and thus, this unspecific activity of the 
226 polymerase may be utilized by the host to restrict viral replication. 
227 Alphavirus polymerase nsP4 has two major biochemical characteristics, de novo RNA 
228 synthesis and TATase activity. The former one requires the other nsPs and the latter one may 
229 generate the poly (A) tail typical of alphaviral genomes. The polymerase fidelity can be altered 
230 and mutations can also result in more frequent recombination. If a crystal structure of 
231 alphaviral polymerase is obtained, it would allow more robust comparison of this polymerase 
232 to other viral RdRps, beyond the sequence level. As the structures are more conserved than 
233 sequences (Mönttinen et al., 2014), new relationships between RdRp-encoding viruses could 
234 be formed.
235
236
237 3. Minus-strand and plus-strand synthesizing replicases  
238 The core function of the viral polymerase lies in the genome replication but it is not the only 
239 element needed. The replication of alphaviruses is carefully orchestrated and requires all four 
240 nonstructural proteins that are processed from a polyprotein in a precise order during RNA 
241 synthesis (Fig. 2). The nonstructural proteins are translated as a polyprotein in the cytoplasm 
242 from the RNA genome released after virus entry. For most alphaviruses such as SINV, there is 
243 an opal (UGA) termination codon close to the C-terminus of nsP3 and thus two types of 
244 polyproteins, P123 and P1234, are produced. Of these only ~10 % is full-length polyprotein 
245 and P123 is produced in excess (Li and Rice, 1993). In contrast, SFV and ONNV have the stop 
246 codon replaced by arginine and only P1234 is produced (Strauss and Strauss, 1994; Takkinen, 
247 1986). After translation, nsP4 is promptly cleaved by the protease activity residing in the C-
248 terminus of nsP2 (de Groot et al., 1990). This cleavage is obligatory as the full-length form 
249 P1234 is not capable of any RNA synthesis (Kallio et al., 2016; Shirako and Strauss, 1994). 
250 It has been demonstrated that nsP4 can also be provided separately by expressing it as an 
251 ubiquitin-fusion, which is rapidly cleaved to provide authentic nsP4 (Lemm et al., 1994; Spuul 
252 et al., 2011). The N-terminal amino acid of nsP4 has a critical role in its functionality. In the 
253 wild type form, nsP4 contains tyrosine as the N-terminal amino acid (Strauss and Strauss, 
254 1994) and excess nsP4 is rapidly degraded by the N-end rule pathway, a ubiquitin-dependent 
9255 proteolysis (de Groot et al., 1991). In this process the protein’s N-terminal amino acid plays a 
256 key role and tyrosine acts as a destabilizing residue (Varshavsky, 1992). Changing the N-
257 terminal amino acid to a nonaromatic residue in nsP4 is lethal for the virus, but an aromatic 
258 amino acid (Phe or Trp) or histidine rescues replication close to wild type level (Shirako and 
259 Strauss, 1998). An N-terminal Met results in viable virus with attenuated replication (Shirako 
260 and Strauss, 1998). Three second-site suppressor mutations resulting in amino acid 
261 substitutions allow the mutant SINV nsP4 with an N-terminal nonaromatic amino acid (Ala, 
262 Leu or Arg), to be functional. One suppressor mutation is located in nsP1  and two in nsP4 
263 (Shirako et al., 2000). These results suggest that the role of the conserved tyrosine at the N-
264 terminus of nsP4 is to interact with nsP1 and other nsP4 residues to allow proper folding 
265 and/or to interact with other viral or cellular factors to recognize the promoter and thus allow 
266 efficient initiation of the minus-strand synthesis. The ring structure of the aromatic amino 
267 acids may allow the right conformation for proper protein folding and protein-protein 
268 interactions (Shirako et al., 2000; Shirako and Strauss, 1998). 
269 The early polymerase complex formed by P123 and nsP4 is dedicated to the synthesis of 
270 minus strand, using the viral genome as template (Lemm et al., 1994; Shirako and Strauss, 
271 1994). This form of the complex is able to synthesize some plus-strand RNAs, but very 
272 inefficiently (Kallio et al., 2016; Lemm and Rice, 1993b). The following cleavage of nsP1 from 
273 P123 switches the complex in such a way that for a very short period, a complex of 
274 nsP1+P23+nsP4, seems to be capable of both minus and plus strand synthesis, but not 
275 subgenomic RNA synthesis (Jose et al., 2009; van der Heijden and Bol, 2002). The site between 
276 nsP2 and nsP3 is then cleaved in trans, leading to fully processed nonstructural proteins, 
277 forming the late RC. The switch to the late complex irreversibly “locks” the complex and it can 
278 only synthesize full length and subgenomic plus-strand RNAs from the minus strand. Thus in 
279 order to produce more minus strands, more polyprotein precursors should be translated. This 
280 has been demonstrated by treatment of cells with cyclohexamide which quickly shuts off the 
281 minus strand RNA synthesis (Sawicki and Sawicki, 1980; Sawicki and Sawicki, 1986). In infected 
282 mammalian cells, minus-strand synthesis occurs efficiently until 3 to 4 hours post infection 
283 (p.i.) and is then shut down as polyprotein cleavage becomes so rapid that new RCs can no 
284 longer be formed (Sawicki and Sawicki, 1980). 
285 The polyprotein cleavage and its relation to strand-preference has been widely studied 
286 with the classic alphaviruses SFV and SINV. Different experimental strategies, such as 
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287 cleavage-defective polyproteins and proteases (Lemm et al., 1998; Lemm and Rice, 1993b; 
288 Lemm et al., 1994; Shirako and Strauss, 1994; Vasiljeva et al., 2003), temperature-sensitive 
289 mutants (Hahn et al., 1989b; Sawicki et al., 1990; Sawicki and Sawicki, 1993; Sawicki et al., 
290 1981; Wang et al., 1994) and reconstituted systems (Lemm and Rice, 1993a, b; Lemm et al., 
291 1994; Spuul et al., 2011), have been used to gain a comprehensive set of results. It has been 
292 clearly shown that in order to synthetize minus-strands, the nonstructural proteins nsP1, nsP2 
293 and nsP3 cannot be expressed separately but are needed as a polyprotein P123 (Lemm and 
294 Rice, 1993a; Lemm et al., 1994; Shirako and Strauss, 1994). In fact, even if P123 is expressed 
295 but is processed to individual proteins too fast, no RNA synthesis is detected (Lemm et al., 
296 1994). A specific role for nsP1 in the minus-strand synthesis has been detected with SINV 
297 mutant ts11, which contains Ala-348 to Thr substitution in the nsP1 (Hahn et al., 1989b) and 
298 SFV mutants ts10 and ts14 (Lulla et al., 2008). Similarly, another mutant ts4 in SINV, mapping 
299 to nsP3 (Ala268 to Val), plays a role in minus-strand synthesis (Wang et al., 1994). All these 
300 mutants fail to synthesize minus-strand when infected cells are shifted from permissive to 
301 nonpermissive temperature. 
302 Subsequent robust plus-strand RNA synthesis happens in the late RCs containing cleaved 
303 polyproteins, when subgenomic RNAs are produced in higher quantities than genomic RNAs 
304 (Keränen and Kääriäinen, 1979). Studies with uncleavable P123 or P23 have demonstrated 
305 that production of subgenomic RNA is impaired when fully processed nsPs are not present 
306 (Gorchakov et al., 2008a; Lemm and Rice, 1993b; Lemm et al., 1994; Shirako and Strauss, 
307 1994). Interestingly, it has been possible to reactive minus-strand synthesis with a number of 
308 ts mutants in the absence of new protein synthesis (Sawicki and Sawicki, 1993; Suopanki et 
309 al., 1998), implying that the conformational changes is the nsPs between early and late RCs 
310 are so subtle that cleaved nsPs are able to switch back to the early complex form (reviewed 
311 in (Kääriäinen and Ahola, 2002)). A replicase containing uncleavable P123, with additional 
312 adaptive mutations, can also convert to the late form making only positive-strand RNAs 
313 (Gorchakov et al., 2008a).
314 The delicate interactions between the nsPs in the replication complex at the early and 
315 late stages are poorly understood due to the lack of structural data. A number of studies have 
316 addressed the role of nsP4 amino acid substitutions both in replication and in protein-protein 
317 interactions.  It has been suggested that the conserved arginine 183 of SINV nsP4, which is 
318 predicted to be in the fingers domain, plays an important role in the initiation of the minus-
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319 strand synthesis and the interaction with host factors (Fata et al., 2002a). In addition, Gly83 
320 to Leu substitution in the N-terminal domain of nsP4 also affects minus-strand RNA synthesis 
321 (Rupp et al., 2011). These minus-strand deficient mutants can be suppressed by second-site 
322 mutations in nsP1 indicating that nsP1 and nsP4 interact (Fata et al., 2002b; Rupp et al., 2011). 
323 Physical connection identified between nsP1 and nsP4 further confirms their interaction (Fata 
324 et al., 2002b; Lulla et al., 2008; Salonen et al., 2003; Shirako et al., 2000; Shirako and Strauss, 
325 1998; Sreejith et al., 2012). Furthermore, second-site mutations in nsP2 and nsP3 suppress 
326 Asp41 to Ala substitution in nsP4, which results in defects in subgenomic RNA synthesis (Rupp 
327 et al., 2011). Altogether, the suppressor mutations imply that the N-terminal domain of nsP4 
328 interacts with all three other nsPs to activate RNA synthesis (Fata et al., 2002b; Rupp et al., 
329 2011). It is suggested that this domain, due to its flexible nature, forms different contacts at 
330 different steps during the replication to allow the synthesis of different RNA species (Rupp et 
331 al., 2011).
332 A different type of experimental approach, relying on vaccinia virus based replication 
333 systems, has been very useful in understanding the different stages of RNA synthesis and the 
334 role of polyprotein cleavage (Lemm et al., 1994). More recently, a plasmid-based trans-
335 replication system was created for SFV (Spuul et al., 2011). The expression of polyprotein and 
336 template RNA takes place in T7 polymerase expressing cells from transfected DNAs. Thus the 
337 polyprotein or RNA expression is not dependent on replication, allowing studies with a range 
338 of modifications, including lethal ones (Kallio et al., 2016). It has been shown that capping 
339 activity, residing in nsP1, is not needed for negative strand synthesis, while many other 
340 enzymatic functions of the nsPs (helicase, protease and polymerase activities) and failure to 
341 bind to membranes totally abolished replication (Kallio et al., 2016). Similar systems have also 
342 been published for SINV (Frolova et al., 2010) and CHIKV (Utt et al., 2016). The latter has also 
343 been constructed as a cytomegalovirus-promoter driven system, allowing expression in wide 
344 range of cell types (Utt et al., 2016). 
345 Several studies have shown that the positive-strand RNA template can be provided to the 
346 replicase in trans and is efficiently replicated (Lemm and Rice, 1993a, b; Spuul et al., 2011). 
347 However, attempts to similarly introduce minus-strand RNA templates have not succeeded 
348 (Hellström et al., 2016; Lemm et al., 1998), indicating that the replication can start only from 
349 plus-strand RNA. According to recent findings, minus strands are protected from RNase inside 
350 the spherules when RCs are isolated as membrane preparations (Kallio et al., 2016). This 
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351 suggests that the minus strands are strictly segregated inside the spherules. Therefore, in 
352 normal situations, the minus strands would not be available as starting points for replication 
353 and there would be no advantage in having a mechanism to directly recruit the minus strand 
354 (Hellström et al., 2016).
355
356
357 4. Promoter recognition by the polymerase
358 A determining step of replication is when the polymerase recognizes and binds to the 
359 promoters. CSEs in the genome are thought to be recognized by the polymerase complex in 
360 the different stages of RNA replication (Rupp et al., 2015). The 5′ end of the genome contains 
361 two CSEs, one in the 5′ untranslated region (UTR) and the other one within the nsP1 coding 
362 region, both forming stem-loop secondary structures (Frolov et al., 2001; Nickens and Hardy, 
363 2008; Niesters and Strauss, 1990a, b; Ou et al., 1983). The two stem-loops formed by the 51-
364 nt CSE within the nsP1 region enhance both minus- and plus-strand RNA synthesis but they 
365 are dispensable for RNA replication. In contrast, the 5’ UTR CSE contains essential promoter 
366 elements for both minus- and plus-strand synthesis. However, different alphaviruses might 
367 use different 5’ elements for RNA synthesis as well as bind different host factors needed for 
368 RNA synthesis (Frolov et al., 2001; Gorchakov et al., 2004). The subgenomic promoter forms 
369 the third CSE, and a short CSE is located at the very 3′ end of the genome immediately 
370 preceding the poly(A) tail. The core promoter of the minus-strand RNA synthesis is composed 
371 of the 3’ CSE and poly(A) tail (Hardy and Rice, 2005; Rupp et al., 2015). 
372 4.1. Minus-strand RNA synthesis
373 Efficient minus-strand RNA synthesis of SINV requires that 1) the length of the poly(A) tail is 
374 at least 11-12 residues, 2) the 3’ CSE immediately precedes the poly(A) tail, and 3) the 3’ 13 
375 nucleotides of the 3’ CSE are not changed (Hardy and Rice, 2005). It still remains unclear how 
376 alphaviruses initiate the minus-strand synthesis, but is has been suggested that they employ 
377 poly(A)-binding protein (PABP) and a similar genome-circularization mechanism as poliovirus, 
378 which uses a protein primer-dependent initiation on the 3’ poly(A) tail (Frolov et al., 2001; 
379 Hardy and Rice, 2005; Peersen, 2017). It has been shown that the minimal length requirement 
380 of the SINV poly(A) tail is the same as that required for efficient binding of PABP (Deo et al., 
381 1999; Hardy and Rice, 2005). Frolov et al. (2001) have suggested a model of how the 5’ and 3’ 
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382 ends of the alphavirus genome interact to initiate minus-strand RNA synthesis. It is 
383 hypothesized that the viral RCs assemble on the 5’ end of the genome with translational 
384 machinery and possibly other host factors, and the interaction between the translation 
385 factors with PABP brings the 5’ and 3’ ends together. This is supported by competition assays 
386 where the 5’ competitor RNA strongly inhibits minus-strand RNA synthesis, indicating that the 
387 5’ end binds limiting viral or cellular factors needed for the minus-strand RNA synthesis 
388 (Frolov et al., 2001). 
389 Initiation site localization of the minus-strand RNA synthesis is dependent on the 
390 poly(A) tail and the last three 3’ residues of the 3’ CSE (Hardy, 2006). The predominant 
391 initiation site of the minus-strand synthesis is the cytidylate residue immediately preceding 
392 the poly(A) tail, and this cytidylate is conserved among the alphaviruses (Adkins et al., 1998; 
393 Hardy, 2006). The following residues up to +12 from the initiating residue are hypothesized 
394 to be important for the transition from initiation to elongation and/or promoter recognition 
395 (Hardy, 2006).
396 4.2. Plus-strand RNA synthesis
397 The initiation site for the plus-strand RNA synthesis, both genomic and subgenomic, is highly 
398 conserved in the alphavirus genomes, and always starts with adenylate-uridylate, except that 
399 BFV has an extra uridylate residue at the 3’ end of the minus strand (Adkins et al., 1998). The 
400 promoter for the genomic RNA synthesis is located at the 3’ end of the minus strand within 
401 the region corresponding to the 5’ UTR stem loop sequence, and a complementary stem-loop 
402 structure has been predicted for the minus strand as well. The critical nucleotides for the SINV 
403 genomic promoter include those at positions 2 to 5 from the 3’ end of the minus strand 
404 (Frolov et al., 2001; Gorchakov et al., 2004; Li and Stollar, 2007; Niesters and Strauss, 1990a; 
405 Ou et al., 1983; Thal et al., 2007). The minimal promoter sequence required for the synthesis 
406 of SINV subgenomic RNA includes -19 to +5 nucleotides from the initiation site (Levis et al., 
407 1990; Li et al., 2005), and nucleotides -17, -14, -13, and -11 relative to the initiation site are 
408 highly conserved among alphaviruses (Siegel et al., 1997).
409 Regulation of positive-strand RNAs synthesis, both genomic and subgenomic, is 
410 dependent on nsP4 as different sites of nsP4 bind the respective promoters (Li and Stollar, 
411 2004, 2007; Li et al., 2010). Crosslinking and gel mobility-shift assays revealed that the peptide 
412 corresponding to residues 329-334 of nsP4 binds to the subgenomic promoter of SINV. This 
413 fragment is predicted to be on a β-strand in the fingers domain. Furthermore, nsP4 is able to 
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414 bind to the subgenomic promoter only when all four nsPs are present suggesting that the 
415 other nsPs affect the conformation of nsP4 (Li and Stollar, 2004). The peptide corresponding 
416 to residues 531-538 of nsP4 binds the promoter for the genomic RNA synthesis (Li and Stollar, 
417 2007; Li et al., 2010). Furthermore, mutations in nsP4, which abolish the subgenomic RNA 
418 synthesis, have no effect on the genomic RNA synthesis and vice versa (Li and Stollar, 2007; 
419 Li et al., 2010).
420 Alphaviruses typically make more subgenomic than genomic RNA in infected cells 
421 (Keränen and Kääriäinen, 1979). However, the PFZ- and CPC-resistant mutants of SINV 
422 synthesize more genomic than subgenomic RNA, and except for one, the mutations are in the 
423 region of both nsP4-coding sequence and subgenomic promoter (Li et al., 2008; Li et al., 2004; 
424 Li et al., 2010; Lin et al., 2002; Lin et al., 2000). It has been shown that the changed RNA ratio 
425 is mainly due to the changes in the promoter sequence (Li et al., 2010). The genomic / 
426 subgenomic RNA ratio made by these mutants in vitro is also affected by the nucleotide 
427 concentrations used in the reaction mixture indicating that the NTP concentrations affect 
428 which promoter the polymerase chooses. Thus, the cytoplasmic NTP concentration may 
429 affect the activity of the viral polymerase (Li et al., 2008; Li et al., 2010). Additionally, defects 
430 in subgenomic RNA synthesis are detected with some ts mutants like SFV ts4 and SINV ts15, 
431 ts17, ts18, ts24 and ts133 (Kääriäinen and Ahola, 2002; Sawicki and Sawicki, 1985; Suopanki 
432 et al., 1998) which all map to nsP2. Therefore, nsP2 may be required to recognize the 
433 subgenomic promoter in the minus strand RNA.
434 The requirement for an aromatic amino acid at the N-terminus of nsP4 is also interesting 
435 with respect to the plus-strand RNA synthesis. Besides suppressor mutations in nsP1 or nsP4, 
436 addition of AU, AUA, or AUU to the 5’ terminus of the genome or substitution of the third 
437 nucleotide of the genome, A for U, restore the activity of the SINV polymerase mutant with 
438 an N-terminal nonaromatic amino acid (Ala, Leu, or Met) (Shirako et al., 2003). It is speculated 
439 the polymerase mutants with a nonaromatic amino acid at the N-terminus are unable to open 
440 the stem-loop structure at the 3’ terminus of the minus strand to initiate plus-strand RNA 
441 synthesis, and the addition of AU-rich sequences or the A-U substitution enables the 
442 polymerase mutants to work. Thus, it is proposed that the N-terminus of the polymerase 
443 forms direct contacts with the 3’ terminus of the minus strand to initiate plus-strand RNA 
444 synthesis (Shirako et al., 2003). However, minus-strand synthesis of the polymerase mutant 
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445 must also be restored, and consequently the addition of these AU-rich sequences to the 5’ 
446 terminus of the genome most likely play a role also in minus-strand synthesis.
447 To summarize, the initiation sites of RNA synthesis are highly conserved in the 
448 alphavirus genomes. The 3’ CSE and poly(A) tail form the core promoter of the minus-strand 
449 RNA, and the minus strand region corresponding to the 5’ UTR stem loop forms the promoter 
450 for the genomic RNA. The CSE within the 5’ UTR is important also for minus-strand RNA 
451 synthesis. Different sites of nsP4 bind the genomic and subgenomic promoters, and nsP2 may 
452 also play a role in subgenomic promoter recognition.
453
454
455 5. Membrane association of replication – spherules 
456 Early studies with SFV by Grimley et al. already suggested that the replication of alphaviruses 
457 takes place in membrane-associated structures called spherules, located either on the plasma 
458 membrane or on the limiting membranes of type I cytopathic vacuoles (CPV-I), which are 600-
459 2000 nanometres in diameter (Grimley et al., 1968; Grimley et al., 1972). Spherules 
460 themselves are about 50-60 nm membrane invaginations that are connected to the cytoplasm 
461 by a narrow neck, allowing export of the nascent RNA (Fig. 3). The spherules contain dense 
462 material, presumably representing RNA (Froshauer et al., 1988). The association of nsPs 
463 (Froshauer et al., 1988; Kujala et al., 2001) and localization of dsRNA staining with spherules 
464 (Frolova et al., 2010; Spuul et al., 2010) have been nicely demonstrated, strengthening the 
465 view that they are the site of viral replication. The composition of the spherules is, however, 
466 poorly understood, and the amount of the nsPs in each spherule is unknown but has been 
467 estimated to be quite low (Frolova et al., 2010).
468 In addition to spherules, nsPs are found in different, but specific places, within the cells. 
469 Characteristic localization of nsP1 on the inner surface of the plasma membrane (Spuul et al., 
470 2007) results from its palmitoylation (Laakkonen et al., 1996; Peränen et al., 1995) and 
471 membrane binding amphipathic peptide (Ahola et al., 2000; Ahola et al., 1999; Lampio et al., 
472 2000). By contrast, nsP2 is found in the nucleus due to the nuclear localization signal in its C-
473 terminus (Peränen et al., 1990; Rikkonen et al., 1992). The C-terminal motif of nsP3 on the 
474 other hand is responsible for binding cellular proteins such as Ras-GTPase-activating protein 
475 (SH3 domain)-binding proteins 1 and 2 (G3BP1 and G3BP2) (Fros et al., 2012; Panas et al., 
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476 2012; Scholte et al., 2015) for Old World alphaviruses and Fragile X syndrome family (FXR) 
477 proteins for New World alphaviruses like VEEV (Foy et al., 2013; Kim et al., 2016), leading to 
478 formation of cytoplasmic aggregates where nsP3 accumulates (Frolova et al., 2006; 
479 Gorchakov et al., 2008b). nsP4 is detected diffusely in the cytoplasm (Kujala et al., 2001), 
480 though most of it is quickly degraded as mentioned in above. However, a resistant, stable 
481 fraction of nsP4 has been detected and is postulated to be the one that is associated with RCs 
482 and is thus protected from degradation (de Groot et al., 1991). SINV nsP4 synthesized early 
483 in infection is more stable than the one made late in infection. This would be consistent with 
484 the hypothesis that assembly of nsP4 in the RCs protects the protein (de Groot et al., 1990; 
485 de Groot et al., 1991; Hardy et al., 1990; Hardy and Strauss, 1988). When lysates from SFV-
486 infected cells are separated into a nuclear pellet and post-nuclear supernatant  and the 
487 supernatant is further separated into a membrane and cytosolic fractions, most of SFV nsP4 
488 is found in the membrane fraction (Peränen et al., 1988),indicating that the stable fraction of 
489 nsP4 is associated with membranes.
490 Spherules are part of the cellular membrane trafficking network. For example, SFV 
491 spherules are originally formed at the plasma membrane and are then internalized (Spuul et 
492 al., 2010), leading to spherule-lined, modified late endosomal/lysosomal CPVs that are often 
493 in the vicinity of rough endoplasmic reticulum (Froshauer et al., 1988). In a recent study, it 
494 was observed that in contrast to SFV, only a fraction of SINV spherules are internalized. 
495 However, some CPVs can be detected later during the SINV infection (Frolova et al., 2010). 
496 The internalization has been extensively studied with SFV and has been shown to be 
497 dependent on the activity of phosphatidylinositol-3-kinase (PI3K) (Spuul et al., 2010). In a 
498 recent study by Thaa et al. (2015) the RC internalization was compared between SFV and 
499 CHIKV and was further linked to the activation of PI3K-Akt-mTOR pathway. The study showed 
500 that the hyperphosphorylated/acidic domain of nsP3 is responsible for the pathway activation 
501 and that SFV and CHIKV greatly differed in this respect; while SFV boosted the pathway and 
502 showed efficient spherule internalization, CHIKV RCs stayed mostly at the plasma membrane. 
503 By exchanging the responsible domain from SFV to CHIKV, it was possible to obtain pathway 
504 boosting and RC internalization also with CHIKV (Thaa et al., 2015). In addition, the early steps 
505 during SFV spherule internalization need an intact actin network, while microtubules are 
506 necessary for later CPV accumulation in the perinuclear region. However, it has been shown 
507 that the internalization from the plasma membrane is not necessary for active replication, but 
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508 is rather speculated to be involved in protecting virus production from cellular defence 
509 mechanisms (Spuul et al., 2010). 
510 How the spherules are formed is still under study. For example, the exact mechanism 
511 and place of the RNA recruitment is not known but the RC needs to be membrane associated 
512 (Salonen et al., 2003; Spuul et al., 2007). It has been shown that all four replicase proteins 
513 need to be present for spherules to form. Active replication, or at least minus-strand synthesis 
514 is a prerequisite for spherule formation (Frolova et al., 2010; Hellström et al., 2016; Kallio et 
515 al., 2016; Spuul et al., 2011), in accordance with the studies where the inactivation of the 
516 polymerase nsP4  abolishes spherules (Kallio et al., 2016; Spuul et al., 2011; Utt et al., 2016). 
517 In a recent study, it was demonstrated that the spherule size could be manipulated by 
518 changing the template length (Kallio et al., 2013), thus indicating that the spherule is not a 
519 rigid structure but can be somewhat flexible. The role of host proteins in the spherule 
520 formation is largely unknown, but amphiphysins have been shown to participate in replication 
521 through nsP3 interactions. Since they are membrane binding proteins inducing positive 
522 curvature, it is possible that they participate in spherule formation where positive curvature 
523 is found on the neck structure (Neuvonen et al., 2011). 
524 While the spherules are shown to locate on plasma membrane and CPVs for 
525 alphaviruses, the other positive-strand RNA viruses use other membrane types for their 
526 replication. Rubella virus, the only member of the genus Rubivirus is replicating on the 
527 lysososomal-originated CPVs as do alphaviruses, but not on the plasma membrane (Kujala et 
528 al., 1999). Brome mosaic virus, belonging to the alphavirus-like superfamily, induces 
529 spherules at the endoplasmic reticulum, which is also the site of invaginated vesicles formed 
530 by flaviviruses, e.g. dengue and West Nile virus. Instead, the spherules of the nodavirus Flock 
531 House virus are found on the outer mitochondrial membrane. Some plant viruses employ 
532 plant-specific membranes such as chloroplasts (turnip yellow mosaic virus) and peroxisomes 
533 (tomato bushy stunt virus) for the membranous RC formation (reviewed in (Paul and 
534 Bartenschlager, 2013; Romero-Brey and Bartenschlager, 2014; Stapleford and Miller, 2010)). 
535 Thus it is likely that even though the RC structures of these viruses resemble each other, the 
536 required cellular components significantly differ due to the variable intracellular location.
537 In spite of the development of advanced electron microscopy techniques and the 
538 extensive studies of many plus-strand viruses, the ultrastructure, molecular components or 
539 formation process of RCs are still largely unknown and many details are missing. The role of 
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540 host proteins, cellular lipids and viral proteins and RNA in cellular membrane rearrangements 
541 for replication purposes are studied by several groups but clearly much is still to be found 
542 (reviewed in (Miller and Krijnse-Locker, 2008; Reid et al., 2015a; Stapleford and Miller, 2010). 
543 In addition, the critical information of nonstructural protein interactions and their 
544 conformational changes within RCs during replication are mainly uncharacterized (Rupp et 
545 al., 2015). However, the reasons for membrane-associated replication seem to be generally 
546 accepted to be the concentration of necessary components to a restricted, specific 
547 cytoplasmic location, to provide scaffold of RC anchorage, to protect the viral RNA from 
548 cellular defence mechanisms and in some cases to link replication and subsequent virus 
549 assembly (Lorizate and Krausslich, 2011; Miller and Krijnse-Locker, 2008; Neufeldt et al., 2016; 
550 Salonen et al., 2005).
551
552  6. Purification of replication complexes and in vitro RNA synthesis
553 One of the outstanding questions in the alphavirus field is the structure and organization of 
554 the RCs as no high-resolution structure is available for the polymerase or the RC. As nsP4 
555 recognizes and binds to the promoter sequences and is active in de novo RNA synthesis only 
556 in the presence of the other nsPs (Li and Stollar, 2004; Rubach et al., 2009), it is necessary to 
557 determine the structure of the active polymerase in association with the other nsPs, i.e. to 
558 determine the RC structure. Although no structure is yet available, several attempts have 
559 been made to purify the active RCs, and the polymerase functions have been studied using in 
560 vitro assays (Albulescu et al., 2014; Barton et al., 1991; Clewley and Kennedy, 1976; Gomatos 
561 et al., 1980; Lemm et al., 1998).
562 Most of the in vitro RNA-synthesizing activity is found in the membrane fraction 
563 prepared from infected cells. All four nsPs are also found in this fraction as well as most of the 
564 minus-strand RNA made in vivo as expected based on its most likely location in the 
565 membranous RCs (Albulescu et al., 2014; Barton et al., 1991; Clewley and Kennedy, 1976; 
566 Gomatos et al., 1980; Peränen et al., 1990; Peränen et al., 1988). Immunoprecipitation assays 
567 with SINV RCs showed that each anti-nsP antibody is able to pull down all four nsPs indicating 
568 that they form a tight complex (Barton et al., 1991). Most of the positive-strand RNA in cells 
569 is released from the RCs during the replication as it is mainly found in the cytosolic fraction 
570 (Albulescu et al., 2014). 
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571 The activity of the RCs in crude membrane fractions also indicates that all the host 
572 factors required for the RNA synthesis are present in the membrane fraction and no soluble 
573 factors are needed. The in vitro RNA synthesis of CHIKV, SINV, and SFV results in the same 
574 RNA species as made in vivo; genomic and subgenomic single-stranded RNA (ssRNA) as well 
575 as dsRNA, which is in replicative form (RF) and/or replicative intermediates (RI) (Fig. 4) 
576 (Albulescu et al., 2014; Clewley and Kennedy, 1976; Michel and Gomatos, 1973; Sreevalsan 
577 and Yin, 1969). The majority of the in vitro synthesized RNA is in a single-stranded form, and 
578 CHIKV virus synthesizes three ssRNA species, all of positive-polarity: subgenomic and genomic 
579 RNA as well as RNA II which is a ~7.5-kb fragment preceding the subgenomic promoter 
580 (Albulescu et al., 2014; Clewley and Kennedy, 1976). Kinetics studies with SFV have shown 
581 that RF and RI dsRNA are synthesized first and serve as precursors for 26S and 42S ssRNAs, 
582 which are then synthesized at a linear rate (Michel and Gomatos, 1973). Both 26S and 42S 
583 ssRNAs synthesized in vitro are also methylated. The methylation occurs at the 5’ terminus of 
584 the RNA strands and the cap structure is the same as in cells. Furthermore, the methylation 
585 activity co-purifies with the polymerase activity although the in vitro synthesis of ssRNAs is 
586 not dependent on the methylation (Cross and Gomatos, 1981).
587 The in vitro polymerase activity of CHIKV is relatively stable between 20 and 37°C 
588 reflecting the need of alphaviruses to replicate both in mosquito and mammalian cells. One 
589 third of the in vitro ssRNA made by CHIKV is in RIs and the rest is released from the RCs. The 
590 newly made RNA is rather stable indicating some mode of protection, and it is suggested that 
591 membrane association, polysomes, RNA structure, or its encapsidation provide this 
592 (Albulescu et al., 2014). For SFV, it has also been indicated that the RNA species synthesized 
593 in vitro are associated with some structures and do not occur in a free form (Michel and 
594 Gomatos, 1973). 
595 Ultracentrifugation in sucrose-density gradients has been the main method to purify 
596 the alphavirus RCs. A cytoplasmic complex isolated from SINV-infected cells synthesized in 
597 vitro ssRNA, RF, and maybe also RIs, and membrane association of the structure was proposed 
598 based on the detergent and nuclease treatments (Sreevalsan and Yin, 1969). A similar 
599 approach was used to show that SFV polymerase activity, viral RNA, and CPVs enrich in the 
600 same fraction. Furthermore, as the isolated CPVs contained viral RNA, their central role in 
601 RNA replication was indicated (Friedman et al., 1972). In another SFV study, in vivo pulse-
602 labeled RNA and polymerase activity enriched in the smooth-membrane fraction, which 
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603 synthesized and released 26S and 42S ssRNA. Addition of the cytosolic fraction to the smooth-
604 membrane fraction did not increase the polymerase activity indicating that no soluble factors 
605 are needed for the in vitro RNA synthesis (Gomatos et al., 1980). 
606 Detergent solubilisation has also been used in many approaches to purify the alphavirus 
607 RCs (Barton et al., 1991; Clewley and Kennedy, 1976; Gomatos et al., 1980; Ranki and 
608 Kääriäinen, 1979). However, all these protocols seem to affect the activity of the polymerase 
609 demonstrating the central role of membrane association. First, Clewley and Kennedy (1976) 
610 developed a multi-step purification scheme to purify SFV RCs by ultracentrifugation in density 
611 gradients, detergent solubilisation, and affinity chromatography. Although the polymerase 
612 was purified over 300-fold, the recovery of activity was only about 5%. Furthermore, 
613 purification products incorporated label only into RI or RF indicating that the release of ssRNA 
614 was affected and the polymerase was unable to initiate new strands during the in vitro 
615 synthesis (Clewley and Kennedy, 1976). The same inhibition of ssRNA release was observed 
616 when SFV RCs were solubilized from the smooth-membrane fraction, and the polymerase 
617 activity was reduced (Gomatos et al., 1980). Besides, only some of the nsPs were detected in 
618 the solubilized RCs (Clewley and Kennedy, 1976; Gomatos et al., 1980; Ranki and Kääriäinen, 
619 1979). Detergent-solubilized RCs of SINV purified by ultracentrifugation in glycerol and 
620 sucrose gradients have been shown to contain all four nsPs but also these RCs incorporated 
621 label only into RIs (Barton et al., 1991).
622 It is clear that new approaches are needed to obtain highly purified RCs, which remain 
623 active in RNA synthesis. One such approach could be in vitro assembly as alphavirus nsPs are 
624 able to assemble into functional RCs in vitro, and the presence of an endogeonous template 
625 is not a prerequisite for the in vitro RNA synthesis. The membrane fraction containing the 
626 uncleavable polyprotein P123 and polymerase nsP4 of SINV is able to initiate and synthesize 
627 the minus-strand RNA when provided with an exogenous plus-strand RNA template (Lemm 
628 et al., 1998). Expression of nsP1 + uncleavable P23 + nsP4 also enables the in vitro minus-
629 strand synthesis while cleavable P123 + nsP4 results in decreased RNA synthesis confirming 
630 that the polyprotein P23 is necessary for the minus-strand initiation complex. If soluble nsP4 
631 is combined with the membrane fraction containing P123 and an exogenous template is 
632 added, in vitro RNA synthesis is also observed. In addition, nsP4 expressed and purified from 
633 E. coli is able to synthesize RNA in vitro when combined with the P123-membrane fraction 
634 and template (Rubach et al., 2009). Thus, in vitro assembled RCs might represent an 
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635 interesting starting point to solve the structure. Activity-preserving purification method 
636 would then provide a tool to resolve the components, organization, and functional details of 
637 alphavirus RCs. Especially, such an approach would be invaluable in order to determine host 
638 factors crucial for the formation of functional RCs.
639
640
641 7. Host factors and alphavirus polymerase complex
642 Identities and exact roles of host proteins in alphavirus RNA synthesis remains an open 
643 question. Host proteins co-purify with the RCs (Barton et al., 1991; Clewley and Kennedy, 
644 1976), and several host factors interact with alphavirus RNA or nsP-containing complexes (Fig. 
645 5). Mass spectrometry has revealed that SINV nsP2-, nsP3-, or nsP4-containing complexes are 
646 rich in cytoskeleton proteins, chaperons, elongation factors, heterogeneous nuclear 
647 ribonucleoproteins (hnRNPs), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
648 activation proteins (14-3-3 proteins), and ribosomal proteins (Atasheva et al., 2007; Cristea et 
649 al., 2006; Cristea et al., 2010; Frolova et al., 2006; Gorchakov et al., 2008b). A similar set of 
650 proteins, including RNA-binding (e.g. hnRNPs and G3BPs), cytoskeleton (e.g. tubulins), 
651 translation (e.g. eukaryotic translation elongation factors), folding (e.g. heat shock proteins), 
652 and 14-3-3 proteins, were enriched with CPVs isolated from SFV-infected cells (Ahlquist, 
653 2006). The interaction with the host proteins is time-dependent suggesting that different host 
654 proteins are required for the multiple functions of nsP4 at different phases of infection such 
655 as the minus-strand synthesis early, and plus-strand synthesis later in infection (Cristea et al., 
656 2006; Cristea et al., 2010). However, some of the identified host proteins may interact with 
657 nsPs which are not located in the RCs and thus do not affect the polymerase activity.
658 The number of the identified host factors in the SINV nsP3-containing complexes after 
659 a strong detergent treatment was considerably lower than in the other studies (Gorchakov et 
660 al., 2008b). G3BP1 and G3BP2, nucleic acid-binding protein YBX1, and heat shock protein 
661 HSC70 were detected in these samples (Fig. 5). The same nucleic acid-binding and heat shock 
662 proteins have also been detected in SINV nsP2-containing complexes (Atasheva et al., 2007). 
663 In addition, the heat shock protein HSP-90 has been identified in CHIKV nsP3- or nsP4-
664 containing complexes as well as in SINV nsP4-containing complexes (Fig. 5) (Cristea et al., 
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665 2010; Rathore et al., 2014). Furthermore, silencing of HSP-90 inhibits CHIKV replication 
666 (Rathore et al., 2014).
667 In addition to the SINV nsP3-containig complexes, G3BPs have been detected in the 
668 SINV nsP2- and nsP4-containing complexes as well as in the SFV and CHIKV nsP3-containing 
669 complexes (Fig. 5) (Atasheva et al., 2007; Cristea et al., 2006; Cristea et al., 2010; Frolova et 
670 al., 2006; Gorchakov et al., 2008b; Kim et al., 2016; Panas et al., 2014; Panas et al., 2012). The 
671 role of G3BPs in SINV infection has been studied by their knockdown resulting in enhanced 
672 expression of the polyprotein but with minimal effects on RNA synthesis (Cristea et al., 2010). 
673 On the contrary, is has been shown for CHIKV that the depletion of G3BPs results in 
674 significantly reduced levels of the minus-strand RNA, and consequently the plus-strand RNA, 
675 and in reduced replication (Scholte et al., 2015). It was suggested that early in CHIKV infection 
676 G3BPs are essential in the switch from translation to genome replication by possibly removing 
677 the ribosomes from the viral RNA. The authors also show that late in CHIKV infection G3BPs 
678 are found in nsP3 aggregates which are proposed to prevent the formation of typical stress 
679 granules. Interestingly, the same authors also observed reduction in SINV replication in G3BP-
680 depleted cells. It was speculated that G3BP2 levels may not have been low enough in previous 
681 studies to observe the inhibition of replication as it was shown that the knockdown of G3BP2 
682 alone is enough to significantly reduce replication of both CHIKV and SINV. A recent study by 
683 Kim et al. demonstrated how New World and Old World alphaviruses differ in their host 
684 protein selection even though in both groups the stress-granule related proteins are used for 
685 RNA replication and RC assembly. While SINV and CHIKV replication were clearly reduced 
686 when both G3BP homologs were knocked out, similar effect was not seen with VEEV. Instead, 
687 the knockout of FXR family members was specifically affecting VEEV (Kim et al., 2016).
688 The complex formed by nsP3 and G3BP has shown to recruit sphingosine kinase 2 (SK2) 
689 (Fig. 5) (Reid et al., 2015b). In addition, SK2 co-localizes with dsRNA in the infected cells 
690 indicating its presence in the RCs, and most likely nsP3 is responsible for its recruitment to 
691 the RCs. Knockdown of SK2 inhibits CHIKV replication, and during infection SK2 has been 
692 shown to interact with proteins involved in mRNA processing and gene expression such as 
693 poly(C)-binding proteins (PCBPs) 1 and 2. The carboxy-terminal proline-rich motif of SFV, 
694 SINV, and CHIKV nsP3 binds SH3-domains of amphiphysin-1 and -2 (Fig. 5) (Neuvonen et al., 
695 2011). The interaction is important for viral RNA replication, and as amphiphysins work in 
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696 membrane dynamics (Graham and Kozlov, 2010), they might be important for spherule 
697 formation in alphavirus-infected cells (Neuvonen et al., 2011).  
698 Several hnRNPs have been shown to relocalize during alphavirus infections and to 
699 interact with viral components (Ahlquist, 2002, 2006; Ahlquist et al., 2003; Balistreri et al., 
700 2007; Cristea et al., 2006; Frolova et al., 2006; Gui et al., 2010). SINV nsP1, nsP2, and nsP3 as 
701 well as subgenomic RNA but not the genomic RNA co-immunoprecipitate with hnRNP K (Fig. 
702 5), and based on the knockdown of hnRNP K it was speculated that hnRNP K facilitates 
703 transcription of the subgenomic RNA (Ahlquist et al., 2003). Knockdown of hnRNP A1 also 
704 results in reduced SINV replication (Balistreri et al., 2007). It was suggested that hnRNP A1 
705 plays a role in SINV minus-strand RNA synthesis and viral RNA translation as it interacts with 
706 the 5’ UTR. Furthermore, hnRNP A1 interacts with both SINV genomic and subgenomic 
707 promoters, and it has been shown that hnRNP A1 is required for the plus-strand, both 
708 genomic and subgenomic, RNA synthesis (Gui et al., 2010). Several hnRNPs were also 
709 recognized in the CPVs isolated from SFV-infected cells (Ahlquist, 2006). Silencing of RNA-
710 binding proteins hnRNP M and C facilitated SFV, CHIKV, and SINV replication, while silencing 
711 of hnRNP K increased SFV translation but decreased CHIKV and SINV translation. Silencing of 
712 PCBP 1, on the other hand, decreased SFV translation.
713 In addition to hnRNPs, a number of host proteins have been shown to co-purify with 
714 the viral RNA and indicated to play role in the initiation of RNA synthesis. Short 
715 oligonucleotides corresponding to the 3’ end of SINV, SFV, and RRV minus strand bind cellular 
716 proteins, and these might be needed for the initiation of the plus-strand RNA synthesis (Bruce 
717 et al., 2008; Bruce et al., 2010). Mosquito homolog of the La autoantigen binds to the 3’ end 
718 of the SINV minus strands, and it may also play a role in the initiation of the plus-strand RNA 
719 synthesis as the La autoantigen is known to bind to the 3’ oligo(U) terminus of the transcripts 
720 made by RNA polymerase III and to control transcription termination as well as reinitiation by 
721 the polymerase (Buchholz et al., 1999; Chen and Ahlquist, 2000). In addition, mutations in the 
722 5’ cis elements or 3’ UTR of the SINV genome have host-specific effects indicating that these 
723 elements interact with cellular factors (Chen et al., 2001; Frolov et al., 2001; Gorchakov et al., 
724 2004; Niesters and Strauss, 1990a, b). It has been speculated that alphaviruses use PABP in 
725 the genome circularization and thus in the initiation of the minus-strand RNA synthesis, and 
726 PABP has been detected in the nsP2-containing complexes isolated from SINV-infected cells 
727 (Atasheva et al., 2007; Frolov et al., 2001). However, interaction between the poly(A) tail of 
24
728 the genome and PABP remains to be studied. In addition to the initiation, host proteins might 
729 be important in the switch from the minus- to plus-strand RNA synthesis. It has been 
730 suggested that RNase L has a role in the shutoff of the minus-strand RNA synthesis and 
731 formation of stable RCs with transcriptional activity as knockout of RNase L results in 
732 continuous synthesis of the SINV minus- and plus-strand RNA (Sawicki et al., 2003). 
733 To date, no host proteins has been shown to directly interact with the alphavirus polymerase 
734 and affect its activity. Once the structure of the RCs is resolved, we will be able to understand 
735 which host proteins play the most important roles in the function of the polymerase and the 
736 entire RC.
737
738 8. Antivirals and alphavirus polymerase complex
739 CHIKV and related alphaviruses cause febrile illness accompanied by myalgia, arthralgia, and 
740 rash. Although mortality is low, symptoms can last from weeks to months, or even years 
741 (Weaver and Lecuit, 2015). Recent emergence of CHIKV in the Caribbean was followed by 
742 epidemics (Leparc-Goffart et al., 2014) exemplifying the threat that vector-borne alphaviruses 
743 currently have on human health. Consequently, most of the antiviral work on alphaviruses 
744 has focused on CHIKV. Nevertheless, there are no approved, effective antivirals or vaccines 
745 against any human alphavirus (Abdelnabi et al., 2015; Ahola et al., 2015). Here, we focus on 
746 those antivirals which may target viral nsPs or host factors interacting with them.
747 The RNA-dependent RNA polymerase, or the RC, offers a good target for antivirals, and 
748 there are several modified nucleosides against alphaviruses. Nucleoside analog ribavirin, 
749 which causes inhibition of genome replication by depletion of GTP pools, has antiviral activity 
750 against several alphaviruses (Briolant et al., 2004; Leyssen et al., 2006). However, 6-aza-
751 uridine, which causes intracellular UTP depletion, is a more effective antiviral against CHIKV 
752 and SFV than ribavirin (Briolant et al., 2004; Rada and Dragun, 1977; Scholte et al., 2013) 
753 although ribavirin and interferon-α2b have a subsynergistic effect on both viruses (Briolant et 
754 al., 2004). Furthermore, combination of ribavirin and doxycycline, which is a semi-synthetic 
755 tetracycline antibiotic and predicted to bind to nsP2 protease active site and E2 glycoprotein, 
756 gives good antiviral effect on CHIKV by inhibiting both entry and replication (Rothan et al., 
757 2015). Ribavirin 5’-sulfamate, which is a close analog of ribavirin, is also active against SFV but 
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758 it is highly cytotoxic (Smee et al., 1988). Mycophenolic acid inhibits CHIKV replication, even 
759 more efficiently than ribavirin, and the most likely mechanism is also GTP-pool depletion 
760 (Khan et al., 2011; Scholte et al., 2013). A SINV mutant resistant to both mycophenolic acid 
761 and ribavirin has three amino acid changing mutations in nsP1 indicating that these 
762 compounds affect the guanine 7-methyltransferase activity of nsP1 (Scheidel and Stollar, 
763 1991). In contrast, a Gly641 to Asp substitution in nsP2 or a Cys483 to Tyr substitution in nsP4 
764 renders CHIKV resistant to ribavirin and at the same time increases replication fidelity (Coffey 
765 et al., 2011; Stapleford et al., 2015). In contrast to their in vivo effects, ribavirin, 6-aza-uridine, 
766 or mycophenolic acid have no measurable effects on the CHIKV in vitro RNA-synthesizing 
767 activity. It might be that these nucleoside analogs are unable to inhibit CHIKV replication in 
768 vitro as they affect cellular NTP pools and the in vitro assay contains NTPs supplied in excess. 
769 In addition, some of the drugs may not be converted to their active, phosphorylated form 
770 during the in vitro replication assay (Albulescu et al., 2014).
771 Besides the polymerase activity, nsP1 is a promising target of alphavirus antivirals. In 
772 addition to mycophenolic acid and ribavirin, 3-deaza-adenosine inhibits CHIKV replication and 
773 most likely affect nsP1 by interfering of S-adenosylmethionine-dependent methylation (De 
774 Clercq, 1998; Scholte et al., 2013). In addition to nucleotide analogs, a novel class of small 
775 molecules have been observed to inhibit CHIKV, and the resistant variants have a Pro34 to 
776 Ser substitution in nsP1. Using VEEV nsP1, the authors showed that these molecules inhibit 
777 the guanylylation activity of nsP1 (Delang et al., 2016; Gigante et al., 2014).
778 Favipiravir (T-705) is a broad-spectrum antiviral and inhibits RNA viruses most likely by 
779 competing with the incorporation of ATP and GTP (Furuta et al., 2013). Two mechanisms have 
780 been proposed; chain termination or lethal mutagenesis. Favipiravir has been shown to block 
781 replication of both New and Old World alphaviruses, including CHIKV, SFV, SINV, Eastern 
782 equine encephalitis virus, Western equine encephalitis virus, VEEV, ONNV, RRV, and BFV 
783 (Delang et al., 2014; Julander et al., 2009). In addition, defluorinated analogue of favipiravir, 
784 T-1105, has the same effect (Delang et al., 2014). Favipiravir inhibits CHIKV RNA synthesis, 
785 and correlation between CHIKV RNA amount and infectivity decrease indicates that the 
786 mechanism of action is different than the induction of lethal mutagenesis. Low-level 
787 favipiravir-resistant CHIKV variants have a Lys291 to Arg mutation in nsP4, and this lysine is 
788 highly conserved in positive-strand RNA viruses. This suggests that the target site of favipiravir 
789 is the well-conserved region of the RdRp (Delang et al., 2014). 
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790 As mentioned in the previous section, CHIKV and SINV nsP4-containing complexes 
791 interact with HSP-90, and drugs against HSP-90 have been shown inhibit CHIKV replication 
792 (Rathore et al., 2014). A virtual screening simulation was used to find compounds against 
793 CHIKV nsP2, and one of the hits targeting the central part of the protease active site inhibited 
794 CHIKV replication (Bassetto et al., 2013). Continuing from these lead compounds, Das et al. 
795 described a set of related compounds, some of which were shown both to inhibit the nsP2 
796 protease as well as virus replication (Das et al., 2016). Collectively, the number of potential 
797 antivirals against alphaviruses has increased in recent years and it seems that the possibility 
798 to (pre)treat humans is soon at hand. Furthermore, recognition of host factors essential for 
799 the formation and function of the alphaviruses RCs will open more avenues to explore new 
800 antivirals. 
801
802 9. Concluding remarks
803 In spite of the extensive studies on alphavirus replication strategies, the knowledge of the 
804 biochemical and structural properties of the viral polymerase nsP4 is surprisingly limited. This 
805 unusual polymerase apparently cannot act alone but needs the co-operation of and 
806 interaction with the other nonstructural proteins. Many types of experiments have given 
807 important information concerning the activities of both nsP4 and the other nsPs and defined 
808 their roles during RNA synthesis and replication complex assembly.
809 The RCs form membranous invaginations (spherules) on cellular membranes 
810 and are thought to restrict the replication to a protected environment inaccessible to cellular 
811 defence mechanisms. At the same time, spherules gather all the necessary components to a 
812 compact structure, which may limit the activities of the polymerase complex in important 
813 ways. However, very little is still known concerning the cellular proteins that may participate 
814 in spherule formation or function, and how and in what numbers both viral nonstructural 
815 proteins and host proteins are structurally arranged in the RCs. All these details would be 
816 invaluable in order to fully understand how different RNA species are produced, how the RC 
817 switches the strand-specificity and what the exact roles of each nonstructural protein within 
818 a spherule are. It has been shown that the polymerase activity together with the presence of 
819 other nsPs is necessary for spherule formation and that the spherule size is determined by 
820 the length of the RNA template (Kallio et al., 2013). Yet the chronological order of spherule 
27
821 formation steps, including the timing of RNA recruitment and complex assembly are 
822 unresolved. 
823 Alphaviruses are emergently causing epidemics on several continents, but there 
824 are no approved antivirals or vaccines available. The vulnerable replication steps involving 
825 both the nonstructural proteins and the participating host components would be ideal targets 
826 in the fight against these viruses, making it clear that more precise structural and functional 
827 knowledge of the RC is required.
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835 Tables
836 Table 1. Summary of the viruses discussed in this review.
Genus / Family Virus species Abbreviation
Barmah Forest virus BFV
Chikungunya virus CHIKV
Eastern equine encephalitis virus EEEV
O’nyong-nyong virus ONNV
Ross River virus RRV
Semliki Forest virus SFV
Sindbis virus SINV
Venezuelan equine encephalitis virus VEEV
Alphavirus / Togaviridae
Western equine encephalitis virus WEEV
Rubivirus / Togaviridae Rubella virus RUBV
Bromovirus / Bromoviridae Brome mosaic virus BMV
Alphanodavirus / Nodaviridae Flock House virus FHV
837
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838 Figure legends
839 Figure 1. 
840 Alphavirus genome structure. The positive-sense RNA genome is about 11,5 kilobases in 
841 length and contains two open reading frames; first encoding for the nonstructural proteins 
842 (nsPs) 1-4 and second for structural proteins (C, capsid; E1/2/3, envelope glycoproteins and 
843 6K, a 6 kDa protein). UTR, untranslated region; SGP, subgenomic promoter; A(n), polyA.
844
845 Figure 2. 
846 Schematic of the polyprotein processing and RNA synthesis. After disassembly of the 
847 incoming virus particles, the viral plus-strand RNA is released and the nonstructural proteins 
848 are translated as a polyprotein. After cleavage of nsP4, the RC synthesizes minus strand from 
849 the genomic RNA. Further cleavage of all nsPs to individual proteins switches synthesis to 
850 genomic and subgenomic positive-strand RNA. The structural proteins are translated from 
851 subgenomic RNA, leading to the packaging of viral genomic RNA to the forming nucleocapsid.
852
853 Figure 3. 
854 Membranous replication complexes of SFV. A) Spherules located at the plasma membrane at 
855 an early time point. B) Type I cytopathic vacuole (CPV-I) of an infected cell, containing 
856 numerous spherules lining the membrane. C) 3D reconstruction of a single spherule. D) 
857 Schematic of a spherule with replication complex proteins located hypothetically on the neck 
858 region and newly synthesized RNA coming out. The scale bars in A and B are 200 nm and 100 
859 nm, respectively.
860
861 Figure 4. 
862 A schematic model of the replicative form (RF) and replicative intermediate (RI). Purple 
863 indicates the polymerase complex. RI contains several unfinished plus strands. Minus strands 
864 are shown as blue and plus strands as pink.
865
866 Figure 5. 
867 Examples of host proteins identified in alphavirus nsP-containing complexes. nsP1-, nsP2-, 
868 nsP3- and nsP4-containing complexes and their interactions with membrane-curvature 
29
869 proteins amphiphysins, poly(A)-binding protein (PABP), heterogeneous nuclear 
870 ribonucleoprotein K (hnRNP K), nucleic acid-binding protein YBX1, heat shock proteins HSC70 
871 and HSP-90, Ras-GTPase-activating protein (SH3 domain)-binding proteins G3BP1 and 2, and 
872 Sphingosine kinase 2 (SK2).
873
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 Alphavirus core polymerase subunit nsP4 is unable to synthesize RNA on its own. 
 Processing of the replicase polyprotein regulates the stages of RNA replication. 
 RNA replication takes place in special membrane invaginations known as spherules. 
 High-resolution structures for polymerase and the membranous complex are lacking.
